跳至主要内容
临床试验/NCT00711438
NCT00711438已完成2 期

Phase II Pilot Pragmatic Single-Blinded Fast Track Randomised Controlled Trial of the Breathlessness Intervention Service Versus Standard Care for Patients With Chronic Obstructive Pulmonary Disease

Cambridge University Hospitals NHS Foundation Trust1 个研究点 分布在 1 个国家目标入组 13 人开始时间: 2006年4月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
13
试验地点
1
主要终点
Visual Analogue Scale (VAS) - distress due to breathlessness

研究概览

简要总结

The aim of this study is to test the feasibility of conducting a pragmatic fast track Randomized Controlled Trial (RCT) of the Breathlessness Intervention Service (BIS) versus standard care for patients with COPD and their carers, and to begin testing the effectiveness of the intervention.

详细描述

The aim of the study is to test the feasibility of conducting a pragmatic single-blinded fast track RCT of BIS versus standard care for patients with COPD and their carers and to begin testing the effectiveness of the intervention by: (1) Describing the referral patterns and activity of the service; (2) Describing the experiences and views of the service by people with breathlessness who have been referred to it and the experiences and views of those informally involved in their care; (3) Identifying those aspects of the service which are most useful to people with breathlessness, those informally involved in their care and health care professionals.

The study consists of five components: (1) data relating to referral patterns and service activity; (2) identification of components of the intervention; (3) a pilot pragmatic fast-track randomised controlled trial (RCT) of BIS for COPD patients versus standard care; (4) semi-structured interviews with referrers; (5) in-depth interviews with BIS staff. The RCT is described below.

Although the BIS also receives referrals for patients with cancer and heart failure, COPD patients make up the largest diagnostic group of referrals. The pilot trial therefore focuses on a heterogeneous cohort of COPD/COAD patients.

The investigator will be blinded to the allocation of respondents until week 8. This will be achieved by the investigator conducting the recruitment to the study and collecting baseline measures, but then passing the process of randomisation and reporting of allocation (to the patient and provider) over to a third party (clinical trials' nurses) using a random sequence of opaque envelopes previously generated by a study administrator at King's (independent of the service and the RCT). Subsequent to this, all data will be handled using study identity numbers and group allocation identifiers will only be added at the analysis stage. Outcomes are all self-assessed by patients and carers principally using structured questionnaires but also incorporating a qualitative topic guide prior to randomisation and then again at the end of the fast track group's exposure to BIS and the control group's waiting period for BIS (at both of these measurement points structured questionnaires will be completed prior to the qualitative interview).

Subsequent data collected from the control group once they are in receipt of BIS (after their period on the waiting list when their group allocation was blinded to the investigator) will be treated as before/after data and not RCT data. This will allow the collection of qualitative data at the midpoint of using the service as the investigator will no longer be blinded to their group allocation, nor will she be required to be at this stage.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Appropriate referral to the BIS
  • •Diagnosis of COPD/COAD
  • •Aged 18 years or over
  • •Any patient who does not meet any of the

排除标准

  • •The informal carers of patients specified above, who can be significant others, relatives, friends or neighbours
  • •Aged 18 years or over
  • •Any carer who does not meet the exclusion criteria
  • •Exclusion Criteria:
  • •Any patient/carer unable to give informed consent
  • •Any patient living outside of Cambridgeshire PCT, West Essex PCT, East & North Hertfordshire PCT, or Suffolk PCT
  • •Any patient who has previously had access to BIS
  • •Any patient/carer who is demented or confused
  • •Any patient/carer with learning difficulties
  • •Any patient/carer from other vulnerable groups (e.g. head injury, severe trauma, and mental illness)
  • •Any patient/carer who does not meet all of the inclusion criteria

研究组 & 干预措施

FT

Experimental

Breathlessness Intervention Service (BIS)

干预措施: Breathlessness Intervention Service (BIS) (Behavioral)

WL

Active Comparator

Best supportive care

干预措施: Best supportive care (Standard care) (Behavioral)

结局指标

主要结局

Visual Analogue Scale (VAS) - distress due to breathlessness

时间窗: End of intervention (8 weeks after baseline)

次要结局

  • WHO Performance scale(As for primary outcome measure)
  • Carer Burden Interview and Caregiver Appraisal Scale(As for primary outcome measure)
  • Modified BORG(As for primary outcome measure)
  • Mastery scale of CRQ(As for primary outcome measure)
  • VAS breathlessness at best /worst(As for primary outcome measure)
  • SEIQoL-DW(As for primary outcome measure)
  • HADS(As for primary outcome measure)
  • social functioning(As for primary outcome measure)
  • experience of breathlessness & expectations / views of BIS(As for primary outcome measure)

研究者

研究点 (1)

Loading locations...

相似试验

Pilot Randomized Controlled Trial of a... | 临床试验